The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Press release from Business Wire

Questor Pharmaceuticals Stock Plummet Causes Shareholder Investigation by Goldfarb LLP Securities Lawyers

Wednesday, September 26, 2012

Questor Pharmaceuticals Stock Plummet Causes Shareholder Investigation by Goldfarb LLP Securities Lawyers12:22 EDT Wednesday, September 26, 2012 DALLAS (Business Wire) -- Securities lawyers at Goldfarb LLP are investigating alleged violations of shareholder protection laws by officers and directors of Questor Pharmaceuticals. (NASDAQ: QCOR) in connection with an announcement that the Company was under government investigation. Concerned QCOR investors are encouraged to contact attorney Hamilton Lindley at 877-583-2855 or hlindley@goldfarbllp.com about their rights and remedies. “Questor Pharmaceuticals stock plummeted to $18.81 per share after it admitted that the US Government was investigating its promotional practices,” said Hamilton Lindley. “On September 19, Aetna announced that it would only reimburse coverage for only one type of treatment instead of the previous eighteen.” Goldfarb LLP has significant experience representing shareholders in securities lawsuits nationwide. QCOR stockholders – or anyone with knowledge about this situation – should contact lawyer Hamilton Lindley at hlindley@goldfarbllp.com or 877-583-2855 with questions or concerns. Goldfarb LLPHamilton Lindley, 214-583-2233Toll Free Telephone: 877-583-2855Fax Number: 214-583-2234www.goldfarbllp.com